Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Real-world outcomes of Mantle Cell Lymphoma in Colombia: A multicenter cohort study

Blood (2025) 146 (Supplement 1): 7102.

https://doi.org/10.1182/blood-2025-7102

Published: 2025

Journal Articles

Patterns of presentation, treatment, and survival in primary mediastinal B cell lymphoma: A colombian retrospective cohort

Manuela Estrada, Nicolas Duque, Gabriel Ayala, Juliana Castro, Mateo Tamayo, Maria Martinez, Alejandra Melo, Maria Uchima, Martha Romero Prieto, Karen Galvis, Andres Borda Molina, Claudia Agudelo, Beatriz Wills, Guillermo Quintero

Blood (2025) 146 (Supplement 1): 7180.

https://doi.org/10.1182/blood-2025-7180

Published: 2025

Journal Articles

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma

Leon D. Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, Jeremy Abramson, Jacob Soumerai, Maria Martinez-Lage, Julie Haydu, Ganesh Shankar, Chirayu Patel, Bryan D. Choi, Jeffrey Barnes, Areej El-Jawahri, Ephraim Hochberg, Patrick Connor Johnson, Wolfgang Wick, Marcela Maus, Yi-Bin Chen, Matthew Frigault, Jorg Dietrich

Blood (2025) 146 (Supplement 1): 5493.

https://doi.org/10.1182/blood-2025-5493

Published: 2025

Journal Articles

Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy

Blood (2025) 146 (16): 1902–1913.

https://doi.org/10.1182/blood.2025028964

Published: 2025

Includes: Supplemental data

Journal Articles

External Validation of the French Score in Thrombotic Microangiopathies: Real-World Experience in a Large Retrospective Cohort of 1483 Patients

Blood (2024) 144 (Supplement 1): 4000.

https://doi.org/10.1182/blood-2024-204736

Published: 2024

Journal Articles

Flip Side of the Same Coin

Clara Fernández Arias, Olatz Olabarri Etxebarria, Gonzalo Del Campo Balguerías, Alicia Cruz Gómez, María Martínez Rodríguez, Javier Cucharero Martín, Sara Ferrer, Rafael López del Amo, Jorge Martínez Nieto, Ana Villegas, Miguel Gómez Álvarez, Fernando Ataulfo González Fernández, Paloma Ropero Gradilla, Celina Benavente Cuesta, Andrés Felipe Melo Arias

Blood (2024) 144 (Supplement 1): 5546.

https://doi.org/10.1182/blood-2024-207598

Published: 2024

Journal Articles

Autologous Hematopoietic Cell Transplantation in AL Amyloidosis: A Single-Center Experience

Irene Romera, Jorge Verdejo, Inés Viviente, Ana Bocanegra Pérez-Vizcaíno, José Miguel Mateos Pérez, Guiomar Bautista Carrascosa, María Martínez-Muñoz, Jose Luis Bueno, Pablo García Pavía, Manuel Gómez Bueno, Francisco Hernández, Cristina Mitroi, Mercedes Rivas-Lasarte, Javier Segovia-Cubero, Rafael F. Duarte

Blood (2024) 144 (Supplement 1): 6871.

https://doi.org/10.1182/blood-2024-200917

Published: 2024

Journal Articles

Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma

Blood (2024) 144 (10): 1093–1100.

https://doi.org/10.1182/blood.2024023832

Published: 2024

Includes: Supplemental data

Journal Articles

A Rapid Genotyping Assay for CSF Accelerates Diagnosis and Treatment Initiation for CNS Malignancies

Blood (2022) 140 (Supplement 1): 10702–10703.

https://doi.org/10.1182/blood-2022-157077

Published: 2022

Journal Articles

Orthotopic Xenografts Models in Relapse/Refractory Lymphomas: A Preclinical Model for Therapeutic, Mechanistic and Functional Studies

Domingo Domenech Eva, Fina Climent, Eva Gonzalez Barca, Eugenia de Lama, Maria Martinez Iniesta, Monica Calaf, Clara Montane, Ana C Oliveira, Patricia Lopez, Gabriela Sanz-Linares, Esmeralda de la Banda, Laura Arregui, Villanueva Alberto, Anna Sureda, Lourdes Farre

Blood (2022) 140 (Supplement 1): 8829–8830.

https://doi.org/10.1182/blood-2022-164848

Published: 2022

Journal Articles

Identification of Predictive Models Including Polymorphisms in Cytokines Genes Associated with Post-Transplant Complications after Identical HLA-Allogeneic Stem Cell Transplantation

Paula Muñiz Sevilla, María Martínez-García, Mi Kwon, Rebeca Bailén, Gillen Oarbeascoa, Diego Carbonell, Julia Suárez González, María Chicano Lavilla, Cristina Andres, Juan Carlos Triviño, Javier Anguita, José Luis Díez-Martín, Pablo Martínez Olmos, Carolina Martinez-Laperche, Ismael Buño

Blood (2022) 140 (Supplement 1): 4795–4796.

https://doi.org/10.1182/blood-2022-168461

Published: 2022

Journal Articles

A rapid genotyping panel for detection of primary central nervous system lymphoma

Blood (2021) 138 (5): 382–386.

https://doi.org/10.1182/blood.2020010137

Published: 2021

Includes: Supplemental data

Journal Articles

Study of the Effect of Fibrinogen, Factor XIII and Recombinant Activated Factor VII in a Model of Trauma-Induced Coagulopathy

Manuel Quintana, MD PhD, Kapil Nanwani, MD PhD, Charbel Maroun, MD PhD, Elena Elena Muñoz, MD, Ana María Martínez, MD PhD, Mar Gutierrez, MD, Elena G Arias-Salgado, PhD, Dolores Hernández-Maraver, MD, Ana Kerguelen Fuentes, MD PhD, Rosario Torres, MD, Miguel A Canales, MD PhD, Aurora Viejo, MD, Nora V. Butta, PhD, María Teresa Alvarez Román, MD PhD, Víctor Jiménez-Yuste, MD PhD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-142482

Published: 2020

Journal Articles

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Matthew J. Frigault, Jorg Dietrich, Maria Martinez-Lage, Mark Leick, Bryan D. Choi, Zachariah DeFilipp, Yi-Bin Chen, Jeremy Abramson, Jennifer Crombie, Philippe Armand, Lakshmi Nayak, Chris Panzini, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus

Blood (2019) 134 (11): 860–866.

https://doi.org/10.1182/blood.2019001694

Published: 2019

Includes: Supplemental data

Journal Articles

Genetic Predisposition to Molecular Response in Patients with Myeloproliferative Neoplasms Treated with Hydroxycarbamide

Anna Angona, Beatriz Bellosillo, Alberto Alvarez-Larrán, Luz Maria Martinez-Aviles, Laura Camacho, Silvia Pairet, Concepción Fernández, Carles Besses

Blood (2012) 120 (21): 1738.

https://doi.org/10.1182/blood.V120.21.1738.1738

Published: 2012

Journal Articles

TET2 Mutations in a Cohort of Patients with Myeloproliferative Neoplasms Lacking a Molecular Marker.

Luz Maria Martinez-Aviles, Carlos Besses, Alberto Alvarez-Larran, Aina Pons, Sergi Serrano, Beatriz Bellosillo

Blood (2009) 114 (22): 3912.

https://doi.org/10.1182/blood.V114.22.3912.3912

Published: 2009

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Real-world outcomes of Mantle Cell Lymphoma in Colombia: A multicenter cohort study

Patterns of presentation, treatment, and survival in primary mediastinal B cell lymphoma: A colombian retrospective cohort

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma

Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy

External Validation of the French Score in Thrombotic Microangiopathies: Real-World Experience in a Large Retrospective Cohort of 1483 Patients

Flip Side of the Same Coin

Autologous Hematopoietic Cell Transplantation in AL Amyloidosis: A Single-Center Experience

Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma

A Rapid Genotyping Assay for CSF Accelerates Diagnosis and Treatment Initiation for CNS Malignancies

Orthotopic Xenografts Models in Relapse/Refractory Lymphomas: A Preclinical Model for Therapeutic, Mechanistic and Functional Studies

Identification of Predictive Models Including Polymorphisms in Cytokines Genes Associated with Post-Transplant Complications after Identical HLA-Allogeneic Stem Cell Transplantation

A rapid genotyping panel for detection of primary central nervous system lymphoma

Study of the Effect of Fibrinogen, Factor XIII and Recombinant Activated Factor VII in a Model of Trauma-Induced Coagulopathy

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Genetic Predisposition to Molecular Response in Patients with Myeloproliferative Neoplasms Treated with Hydroxycarbamide

TET2 Mutations in a Cohort of Patients with Myeloproliferative Neoplasms Lacking a Molecular Marker.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only